ArticleFrontiers in oncology2022

iRGD-modified exosomes-delivered BCL6 siRNA inhibit the progression of diffuse large B-cell lymphoma.

Qinhua Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.